US FDA Peptide Review Signals Policy Shift, But Manufacturing, Regulatory Hurdles Persist

 
• By Maaisha Osman
  
mortar and pestle mixing drug
An FDA advisory committee will consider lifting restrictions on some peptides after the agency restricted them in 2023. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from United States